Pre-ECTRIMS course
Together with Excemed, ECF will organise a pre-ECTRIMS course on "Patient reported outcomes: new perspectives".
Course Programme "Patient reported outcomes: new perspectives"
Monday 11 October, 2021 (CET)
15.00-15.10 Welcome & Opening
Session 1: Understanding Multiple Sclerosis
- 15.10-15.30 Emerging environmental factors triggering MS: the gut-brain axis S. Baranzini, US
- 15.30-15.50 Immunosenescence and MS A.Bar-Or, Canada
15.50-16.05 Q&A
Session 2: Treating Multiple Sclerosis
- 16.05-16.25 Present and future of treating relapsing MS F.D. Lublin, US
- 16.25-16.45 Present and future of treating progression G. Comi, Italy
16.45-16.55 Break
- 16.55-17.15 Enhancing recovery: new approaches L. Leocani, Italy
- 17.15-17.35 MS and demyelinating diseases in children B. Banwell, US
17.35-17.50 Q&A
Session 3: Monitoring Multiple Sclerosis
- 17.50-18.10 Updated Role of MRI in Monitoring MS F. Barkhof, the Netherlands
- 18.10-18.30 Diagnosis and monitoring of cognitive functions in MS I.K. Penner, Germany
18.30-18.45 Q&A
18.45-19.30 Panel Discussion - Lessons learned from Covid-19 Faculty to be announced
19.30 End of Day 1
Tuesday 12 October, 2021
Session 4: Patient reported outcomes: new perspectives
- 15.01-15.20 The PROMS initiative P. Zaratin, Italy
- 15.20-15.40 Research, validation and development P. Vermersch, France
- 15.40-16.00 Role in clinical management R. McBurney, US
16.00-16.15 Q&A
16.15-16.25 Break
Session 5: MS Controversies 2021- The Future of MS Care
- 16.25-16.45 New evidence on the role of oligodendrocytes and OPCs in MS C. Lubetzki, France
- 16.45-17.05 Moving fluid biomarkers into the clinic M. Comabella, Sapin -J. Kuhle, Switzerland
- 17.05-18.00 Round Table: MS care in this and the next pandemic: transcontinental perspective J. Correale, Argentina; A. Cross, USA; G. Giovannoni, UK
18.00-18.15 Q&A
18.15-18.30 Wrap up and closing remarks
18:30 End of the Workshop
Registration is free of charge, however there are limited places available.
Download the Scientific Programme HERE.
Register NOW.